Sleep Movement Disorder Risk and Your Genetics

What is Sleep Movement Disorder Risk?

Sleep movement disorders encompass a group of neurological conditions in which abnormal, repetitive, or involuntary movements occur during sleep or at the transition between waking and sleeping. The most clinically recognized within this category are restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). Restless legs syndrome is characterized by an uncomfortable, often irresistible urge to move the legs — typically worsening during rest and in the evening — while periodic limb movement disorder involves repetitive limb jerks or twitches during sleep that can fragment sleep architecture without the person necessarily being aware. Both conditions can severely disrupt sleep quality, contributing to daytime fatigue, difficulty concentrating, and reduced quality of life. Understanding the genetic contributors to sleep movement disorder risk can help contextualize personal or family history of these conditions and guide proactive conversations with healthcare providers.

These disorders are far more common than many people realize. Restless legs syndrome affects an estimated 5–10% of adults in Western populations, and periodic limb movements in sleep have an even higher prevalence, particularly in older adults. The two conditions frequently co-occur: the majority of people with restless legs syndrome also have periodic limb movements during sleep, though the reverse is not always true. Clinical assessment typically involves clinical history and, where needed, sleep study data — but genetics now provides an additional layer of context that can help explain familial patterns of occurrence and individual susceptibility.

For informational purposes only. Consult a healthcare provider for clinical guidance.

The genetics behind Sleep Movement Disorder Risk

Genome-wide association studies have identified a rich landscape of genetic loci associated with sleep movement disorders, particularly restless legs syndrome and periodic limb movements. This trait has a robust genetic evidence base, with multiple high-confidence loci identified across several chromosomes.

Among the top-ranked genes from this analysis, KLF12 on chromosome 13 holds the highest L2G score (approximately 0.92), placing it as the lead candidate gene for a key GWAS locus. KLF12 encodes a Krüppel-like transcription factor involved in gene regulation and has been implicated in nervous system development and dopaminergic pathways — systems central to the pathophysiology of restless legs syndrome. ZNF804B on chromosome 7 ranks second (L2G ~0.86), a zinc finger protein involved in transcriptional regulation that has appeared in neurological GWAS signals. LMO1 on chromosome 11 (L2G ~0.86) is a transcription regulator involved in neuronal development, and TTC29 on chromosome 4 (L2G ~0.84) contributes to cellular architecture.

Well-established candidates from the sleep movement disorder literature also appear in this gene set. BTBD9 on chromosome 6 — a BTB/POZ domain-containing protein — is one of the most replicated genetic associations with restless legs syndrome and periodic limb movements, with common variants in this gene repeatedly associated in independent studies. MEIS1 on chromosome 2 is another strongly replicated candidate, encoding a transcription factor involved in neural development and limb patterning. MAP2K5 on chromosome 15 is involved in MAP kinase signaling pathways relevant to neuronal function. Additional ranked genes include BDNF (brain-derived neurotrophic factor), EBF3 (a transcription factor for neuronal differentiation), TOX3, and PTPRD — a protein tyrosine phosphatase with roles in synaptic function and neurological regulation.

The genetic architecture reflects a polygenic pattern, with many loci each contributing modest effects. Key biological themes across the implicated genes include dopaminergic signaling, brain iron homeostasis, and neuronal development — all of which are mechanistically linked to the pathophysiology of sleep movement disorders.

What the research says

The genetic basis of restless legs syndrome and periodic limb movements in sleep has been studied extensively, with genome-wide association studies identifying more than 20 robust loci in recent meta-analyses. These findings have converged on biological pathways involving dopamine neurotransmission, iron metabolism in the brain, and the development and maintenance of sensorimotor neural circuits. The association of BTBD9 with periodic limb movements in sleep was first reported in 2007 and has since been replicated in multiple independent cohorts — making it one of the most consistently observed genetic signals in this domain.

For more information on how ExomeDNA evaluates evidence quality, see our methodology page.

Population-level data suggests restless legs syndrome affects approximately 5–10% of adults, with a notably higher prevalence among individuals of European ancestry compared to East Asian populations — a pattern consistent with the genetic architecture of the trait. Heritability studies estimate that 50–60% of the variance in restless legs syndrome susceptibility is attributable to genetic factors, and twin studies have reinforced the substantial inherited component of this condition.

5–10% of adults in Western populations experience restless legs syndrome, with genetic factors accounting for an estimated 50–60% of susceptibility.^[1]

80%+ of people with restless legs syndrome also exhibit periodic limb movements in sleep, underscoring the overlapping biology of these two conditions.^[1]

Research has also identified meaningful genetic overlap between sleep movement disorders and other neurological and metabolic traits. Shared genetic signals have been reported with iron status markers, gait characteristics, and certain cognitive and psychiatric traits — reflecting the broad role that dopaminergic and iron-handling pathways play across the nervous system.

How Sleep Movement Disorder Risk affects you

For people with a higher genetic loading for sleep movement disorder risk, awareness of personal susceptibility can help explain patterns that might otherwise seem puzzling — why some family members seem to be affected and others are not, or why disrupted, non-restorative sleep has been a persistent experience. Genetics does not determine outcomes, but it can raise or lower the threshold at which these conditions manifest.

The most clinically significant impact of sleep movement disorders is on sleep quality. Fragmented sleep from repetitive limb movements or from the discomfort and urge-to-move of restless legs syndrome can lead to chronic sleep deprivation, which cascades into cognitive impairment, mood disturbances, reduced immune function, and metabolic effects. People with untreated periodic limb movement disorder may not even be aware of their nighttime movements, yet wake feeling unrested and struggle through daytime activities.

Age is a meaningful modifier: the prevalence and severity of sleep movement disorders tend to increase with age, and iron deficiency — including subtle iron deficiency that falls within the normal laboratory range — is a recognized exacerbating factor for restless legs syndrome. Pregnancy is another context in which restless legs symptoms often emerge or worsen, likely due to the interplay of hormonal changes and iron demand.

Sleep movement disorders are also associated with increased rates of cardiovascular events in observational studies, though whether the relationship is causal or reflects shared underlying biology remains an area of ongoing research.

Working with your result

Understanding genetic susceptibility to sleep movement disorders is most useful as a prompt for awareness and proactive monitoring rather than a source of alarm. Many people with elevated genetic susceptibility experience only mild or intermittent symptoms, or none at all. For those who do experience symptoms, effective management options are available.

Iron status evaluation is a recommended starting point for anyone experiencing symptoms consistent with restless legs syndrome. Ferritin levels in the lower range of normal may still contribute to symptom severity, and addressing iron deficiency through dietary changes or supplementation — under medical guidance — can meaningfully reduce symptom burden for some people. Foods rich in iron, such as red meat, leafy greens, and legumes, alongside strategies to enhance iron absorption, are often recommended as a first approach.

Sleep hygiene practices are broadly beneficial: consistent sleep and wake times, reducing caffeine and alcohol intake, and maintaining a cool, quiet sleep environment support better sleep architecture regardless of genetic susceptibility. For restless legs syndrome specifically, avoiding prolonged sitting and incorporating moderate physical activity into daily routines can reduce symptom intensity. Leg stretching, warm baths before bed, and relaxation techniques are commonly recommended supportive measures.

For people whose symptoms are frequent or significantly impact sleep quality, a healthcare provider can evaluate whether medical management is appropriate. Dopamine-modulating agents and other pharmacological options have established evidence in managing restless legs syndrome and periodic limb movement disorder. Genetic information, while not directly guiding treatment decisions, can be one piece of context when discussing susceptibility with a physician or sleep specialist.

For informational purposes only. Consult a healthcare provider for clinical guidance.

Related traits and genes

Sleep movement disorders connect biologically and clinically to a range of adjacent traits that may be informative in the broader context of neurological and sleep health.

Iron metabolism traits are closely linked: brain iron deficiency is a well-established contributor to restless legs syndrome, and genetic variants that influence iron regulation can intersect with sleep movement disorder susceptibility. Dopamine regulation traits are similarly relevant, as the dopaminergic system is central to the pathophysiology of restless legs syndrome and periodic limb movements, and variants affecting dopamine signaling appear in the gene list for this trait.

Migraine susceptibility shows documented genetic overlap with sleep movement disorders, consistent with clinical observations that the two conditions co-occur at higher rates than would be expected by chance. Anxiety and mood-related traits also share genetic pathways, reflecting the shared neurotransmitter systems involved. Gait and motor function traits — as suggested by the GWAS signals connecting sleep movement disorders to gait phenotypes — provide another angle of biological relatedness.

The genes highlighted here — including BTBD9, MEIS1, BDNF, LMO1, and KLF12 — each have functions that extend beyond sleep movement disorders specifically, connecting to broader domains of neurological development, sensorimotor regulation, and dopaminergic biology.

Frequently asked questions

1. Does a higher genetic risk score mean I will develop restless legs syndrome? No. A higher score reflects elevated population-level susceptibility, not a certainty of developing the condition. Many people with elevated genetic loading never experience clinically significant restless legs symptoms. Genetics interacts with iron status, age, lifestyle, and other factors in determining actual outcomes.

2. What are the most common symptoms of sleep movement disorders? Restless legs syndrome typically presents as an uncomfortable urge to move the legs, usually worse at rest and in the evening. Periodic limb movement disorder involves repetitive limb jerks during sleep that can fragment sleep without the person being aware. Daytime sleepiness, difficulty falling asleep, and a sense of non-restorative sleep are common downstream effects.

3. Is iron deficiency connected to sleep movement disorders? Yes. Brain iron deficiency is one of the most consistently recognized contributors to restless legs syndrome. Even ferritin levels within the normal laboratory range may be insufficient for some individuals. Healthcare providers often evaluate iron status as part of the initial assessment for people with restless legs symptoms.

4. Can sleep movement disorders run in families? Yes. Restless legs syndrome has a strong familial component, with heritability estimates around 50–60%. First-degree relatives of affected individuals have substantially higher rates of the condition compared to the general population. The genetic signals identified in GWAS studies are consistent with this familial pattern.

5. Are there lifestyle changes that can help with sleep movement disorders? Yes. For restless legs syndrome, addressing iron deficiency (under medical guidance), maintaining consistent sleep schedules, moderating caffeine and alcohol intake, incorporating regular moderate exercise, and avoiding prolonged sitting can all help reduce symptom burden. Leg stretching and warm baths before bed are commonly recommended supportive strategies.

Written by Scott Peeples, BS Biomedical Sciences · ExomeDNA Founder Reviewed by ExomeDNA Editorial Process Last reviewed: 2026-05-29

References

1. Winkelmann J, et al. Genetics of restless legs syndrome and periodic limb movements in sleep. PMID 39024449.

This page is for educational purposes only. ExomeDNA does not provide clinical guidance. For health-related questions, please consult a qualified healthcare provider.

[FDA Wellness Compliance Footer — content from legal/fda-wellness-footer.md]